Subscribe to RSS

DOI: 10.1055/s-0042-1750108
Vulnerable Carotid Artery Plaques in Asymptomatic Patients—A Narrative Review
Authors

Abstract
Over the last two decades, medical management of carotid artery patients has improved significantly. Most patients remain stable on best medical therapy (BMT), making interventions unnecessary in all patients. “Selective” intervention is advocated for only those few patients who are having vulnerable or unstable carotid artery plaques. Literature search was done to explore current concept and role of available investigations to identify vulnerable carotid plaques. Vulnerable plaque is defined as those plaques having active inflammation, high large necrotic lipid content, neovascularity, thin capsule, surface irregularity, or intraplaque hemorrhage. Ultrasound (US) is the simple, noninvasive, cost-effective investigation to differentiate soft (echolucent) from fibrocalcified (echogenic) plaques. It can also comment on other high-risk plaque features such as plaque volume and area. Contrast-enhanced US can visualize neovascularization and plaque surface irregularities better than conventional US. Computed tomography is limited in identifying most high-risk plaque features and is not useful. High-resolution magnetic resonance imaging is the most accurate and externally validated investigation to characterize most high-risk plaque components. Positron emission tomography has emerged as the most promising dynamic investigation to identify and quantify inflammatory plaques and will be clinically very useful in decision making.
Author's Contribution
Z.U.R. was involved in study concept, investigation, and writing.
Publication History
Article published online:
15 June 2022
© 2022. The Pan Arab Interventional Radiology Society. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997; 349 (9061): 1269-1276
- 2 Fontenelle LJ, Simper SC, Hanson TL. Carotid duplex scan versus angiography in evaluation of carotid artery disease. Am Surg 1994; 60 (11) 864-868
- 3 Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995; 273 (18) 1421-1428
- 4 Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989; 79 (04) 733-743
- 5 Naghavi M, Libby P, Falk E. et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003; 108 (14) 1664-1672
- 6 Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation 2006; 113 (19) 2320-2328
- 7 Ross R. The pathogenesis of atherosclerosis–an update. N Engl J Med 1986; 314 (08) 488-500
- 8
Ross R.
Atherosclerosis–an inflammatory disease. N Engl J Med 1999; 340 (02) 115-126
Reference Ris Wihthout Link
- 9 Langsfeld M, Gray-Weale AC, Lusby RJ. The role of plaque morphology and diameter reduction in the development of new symptoms in asymptomatic carotid arteries. J Vasc Surg 1989; 9 (04) 548-557
- 10 Leahy AL, McCollum PT, Feeley TM. et al. Duplex ultrasonography and selection of patients for carotid endarterectomy: plaque morphology or luminal narrowing?. J Vasc Surg 1988; 8 (05) 558-562
- 11 O'Holleran LW, Kennelly MM, McClurken M, Johnson JM. Natural history of asymptomatic carotid plaque. Five year follow-up study. Am J Surg 1987; 154 (06) 659-662
- 12 Polak JF, Shemanski L, O'Leary DH. et al. Hypoechoic plaque at US of the carotid artery: an independent risk factor for incident stroke in adults aged 65 years or older. Cardiovascular Health Study. Radiology 1998; 208 (03) 649-654
- 13 Doonan RJ, Gorgui J, Veinot JP. et al. Plaque echodensity and textural features are associated with histologic carotid plaque instability. J Vasc Surg 2016; 64 (03) 671-677.e8
- 14 Gray-Weale AC, Graham JC, Burnett JR, Byrne K, Lusby RJ. Carotid artery atheroma: comparison of preoperative B-mode ultrasound appearance with carotid endarterectomy specimen pathology. J Cardiovasc Surg (Torino) 1988; 29 (06) 676-681
- 15 el-Barghouty N, Geroulakos G, Nicolaides A, Androulakis A, Bahal V. Computer-assisted carotid plaque characterisation. Eur J Vasc Endovasc Surg 1995; 9 (04) 389-393
- 16 Spence JD, Eliasziw M, DiCicco M, Hackam DG, Galil R, Lohmann T. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke 2002; 33 (12) 2916-2922
- 17 Coli S, Magnoni M, Sangiorgi G. et al. Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity. J Am Coll Cardiol 2008; 52 (03) 223-230
- 18 Saba L, Saam T, Jäger HR. et al. Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications. Lancet Neurol 2019; 18 (06) 559-572
- 19 Ainsworth CD, Blake CC, Tamayo A, Beletsky V, Fenster A, Spence JD. 3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies. Stroke 2005; 36 (09) 1904-1909
- 20 Saam T, Cai JM, Cai YQ. et al. Carotid plaque composition differs between ethno-racial groups: an MRI pilot study comparing mainland Chinese and American Caucasian patients. Arterioscler Thromb Vasc Biol 2005; 25 (03) 611-616
- 21 Schindler A, Schinner R, Altaf N. et al. Prediction of stroke risk by detection of hemorrhage in carotid plaques: meta-analysis of individual patient data. JACC Cardiovasc Imaging 2020; 13 (2 Pt 1): 395-406
- 22 den Hartog AG, Bovens SM, Koning W. et al. Current status of clinical magnetic resonance imaging for plaque characterisation in patients with carotid artery stenosis. Eur J Vasc Endovasc Surg 2013; 45 (01) 7-21
- 23 Gupta A, Baradaran H, Schweitzer AD. et al. Carotid plaque MRI and stroke risk: a systematic review and meta-analysis. Stroke 2013; 44 (11) 3071-3077
- 24 Cocker MS, Mc Ardle B, Spence JD. et al. Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see. J Nucl Cardiol 2012; 19 (06) 1211-1225
- 25 Small GR, Kazmi M, Dekemp RA, Chow BJ. Established and emerging dose reduction methods in cardiac computed tomography. J Nucl Cardiol 2011; 18 (04) 570-579
- 26 Choi YS, Youn HJ, Chung WB. et al. Uptake of F-18 FDG and ultrasound analysis of carotid plaque. J Nucl Cardiol 2011; 18 (02) 267-272